Recurrence of superficial vein thrombosis in patients with varicose veins
Ημερομηνία
2016Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Objective: To investigate which factors other than history of superficial vein thrombosis (SVT) are associated with recurrent spontaneous SVT episodes in patients with varicose veins (VVs). Materials and methods: Patients with a history of spontaneous SVT and VVs were followed up for a mean period of 55 months. Demographics, comorbidities, and thrombophilia screening test were analyzed. Patients were grouped according to the clinical–etiology–anatomy–pathophysiology classification. A multiple logistic regression analysis with the forward likelihood ratio method was undertaken. Results: Thirteen patients out of 97 had a recurrence SVT episode during the follow-up period. All those patients were identified to have a thrombophilia defect. Protein C and S, antithrombin, and plasminogen deficiencies were more frequently present in patients without recurrence. Gene mutations were present in 38% in the nonrecurrence group and 77% in the recurrence group. After logistic regression analysis, patients with dislipidemia and mutation in prothrombin G20210A (FII) had an increased risk for recurrence by 5.4-fold and 4.6-fold, respectively. No deep vein thrombosis or pulmonary embolism occurred. Conclusions: Dislipidemia and gene mutations of F II are associated with SVT recurrence in patients with VVs. A selection of patients may benefit from anticoagulation in the short term and from VVs intervention in the long term. © 2015, © The Author(s) 2015.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Treatment of superficial vein thrombosis with intermediate dose of tinzaparin: A real word cohort study – The SeVEN EXTension study
Karathanos C., Chatzis D., Latzios P., Papakostas I., Goumas K., Giannoukas A.D., on behalf of the SeVEN EXT Collaborators (2021)Background: To assess the treatment of superficial vein thrombosis (SVT) with intermediate dose of tinzaparin in a setting of real world practice. Methods: Prospective observational study of consecutive patients treated ... -
Advancements in the Treatment of Cerebrovascular Complications of Cancer
Aloizou A.-M., Siokas V., Mentis A.-F.A., Dastamani M., Sokratous M., Xiromerisiou G., Mitsias P.D., Hadjigeorgiou G.M., Dardiotis E. (2020)Purpose of review: To present the new guidelines and therapeutic options regarding cerebrovascular complications of cancer, mainly ischemic stroke, cerebral venous thrombosis (CVT), and leptomeningeal carcinomatosis (LMC). ... -
Low-molecular-weight heparin for prevention of thrombosis: Inverted role
Dailiana, Z. H.; Malizos, K. N.; Varitimidis, S.; Hantes, M.; Basdekis, G.; Rigopoulos, N. (2007)BACKGROUND: Heparin induced thrombosis (HIT) after low-molecular-weight (LMWH) administration for thrombosis prevention is a limb and life threatening condition. METHODS: Two previously healthy individuals, with nonviable ...